iSpecimen Inc. (ISPC) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $4.67M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $4.67M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $4.67M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 5.66M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities |
| Amounts owed to suppliers | 4.67M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due within one year | 124.70K USD | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | (m) | |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $240.90K |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.67M | (m) | (m) | (m) | $5.66M | (m) | $124.70K | (m) | (m) | (m) |
| 2026-03-31 | (m) | $4.71M | (m) | (m) | (m) | $5.80M | (m) | $189.74K | (m) | (m) | (m) |
| 2025-12-31 | (m) | $5.36M | (m) | (m) | (m) | $6.44M | (m) | $192.53K | (m) | (m) | (m) |
| 2025-09-30 | (m) | $4.77M | (m) | (m) | (m) | $5.92M | (m) | $155.51K | (m) | (m) | (m) |
| 2025-06-30 | (m) | $4.32M | (m) | (m) | (m) | $5.41M | (m) | $164.07K | (m) | (m) | (m) |
| 2025-03-31 | (m) | $3.79M | (m) | (m) | (m) | $5.17M | (m) | $270.21K | (m) | (m) | (m) |
| 2024-12-31 | (m) | $4.20M | (m) | (m) | (m) | $6.04M | (m) | $360.71K | (m) | (m) | (m) |
| 2024-09-30 | (m) | $4.06M | (m) | (m) | (m) | $6.55M | (m) | $283.57K | (m) | (m) | (m) |
| 2024-06-30 | (m) | $4.21M | (m) | (m) | (m) | $5.81M | (m) | $258.87K | (m) | (m) | (m) |
| 2024-03-31 | (m) | $3.56M | (m) | (m) | (m) | $5.70M | (m) | $272.68K | (m) | (m) | (m) |
| 2023-12-31 | (m) | $3.93M | (m) | (m) | (m) | $6.08M | (m) | $415.77K | (m) | (m) | (m) |
| 2023-09-30 | (m) | $2.28M | (m) | (m) | (m) | $3.59M | (m) | $46.91K | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.78M | (m) | (m) | (m) | $2.86M | (m) | $89.60K | (m) | (m) | (m) |
| 2023-03-31 | (m) | $2.70M | (m) | (m) | (m) | $3.85M | (m) | $97.66K | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.46M | (m) | (m) | (m) | $4.31M | (m) | $132.34K | (m) | (m) | (m) |
| 2022-09-30 | (m) | $967.74K | (m) | (m) | (m) | $5.52M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $433.03K | (m) | (m) | (m) | $5.10M | (m) | $334.98K | (m) | (m) | (m) |
| 2022-03-31 | (m) | $281.49K | (m) | (m) | (m) | $5.62M | (m) | $567.32K | (m) | (m) | (m) |
| 2021-12-31 | (m) | $832.68K | (m) | (m) | (m) | $5.93M | (m) | $654.75K | (m) | (m) | (m) |
| 2021-09-30 | (m) | $351.42K | (m) | (m) | (m) | $5.53M | (m) | $718.72K | (m) | (m) | (m) |
| 2021-06-30 | (m) | $3.23M | (m) | (m) | (m) | $8.93M | (m) | $802.86K | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.79M | (m) | (m) | (m) | $22.31M | (m) | $873.25K | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |